Ana Carrizosa Anderson

USPTO Granted Patents = 16 (Patent Applications = 16)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 63(Granted Patents)

Location History:

Brookline, MA (US) (2015 - 2021)
Newton, MA (US) (2017 - 2021)
Boston, MA (US) (2023 - 2024)

Company Filing History:

16 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

12 out of 443

The Broad Institute, Inc.

patents

12 out of 8,369

Massachusetts Institute of Technology

Dana-farber-cancer Institute Inc.

patents

6. 1 out of 2,882

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12447213 - Modulation of novel immune checkpoint targets (2025-10-21),

2. 12421557 - Methods for predicting outcomes and treating colorectal cancer using a cell atlas (2025-09-23),

3. 12241053 - Modulation of novel immune checkpoint targets (2025-03-04),

4. 12049643 - Methods and compositions for modulating cytotoxic lymphocyte activity (2024-07-30),

5. 12036240 - Compositions and methods targeting complement component 3 for inhibiting tumor growth (2024-07-16),

6. 11981922 - Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment (2024-05-14),

7. 11957695 - Methods and compositions targeting glucocorticoid signaling for modulating immune responses (2024-04-16),

8. 11897953 - Compositions and methods targeting complement component 3 for inhibiting tumor growth (2024-02-13),

9. 11793787 - Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis (2023-10-24),

10. 11186825 - Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1 (2021-11-30),

11. 11180730 - Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3 (2021-11-23),

12. 10934352 - Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions (2021-03-02),

13. 10822587 - T cell balance gene expression, compositions of matters and methods of use thereof (2020-11-03),

14. 10513540 - Modulation of the immune response (2019-12-24),

15. 9834607 - Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions (2017-12-05),

Title: The Innovative Journey of Ana Carrizosa Anderson

Introduction: Ana Carrizosa Anderson is a pioneering inventor based in Brookline, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Ana Carrizosa Anderson's most recent patents focus on sustainable energy solutions and advanced medical devices, showcasing her versatility and commitment to innovation.

Career Highlights: With a career spanning over two decades, Ana Carrizosa Anderson has established herself as a leading figure in the world of inventions. Her work has been recognized for its creativity and practicality, earning her numerous accolades.

Collaborations: Throughout her career, Ana Carrizosa Anderson has collaborated with top research institutions, universities, and companies to bring her ideas to life. These partnerships have been instrumental in the success of her projects.

Conclusion: Ana Carrizosa Anderson's passion for innovation and dedication to making a positive impact on society through her inventions make her a true trailblazer in the field. Her work continues to inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.